Sequence Connecticut
Precision genomic medicine anchored in one of America's strongest academic medical corridors. Structured CarePathways that turn genetic testing from a cost center into a diagnostic resolution engine.
Regional Infrastructure
Connecticut's Healthcare Strengths
Connecticut concentrates world-class academic medicine, specialized pediatric care, and extensive community health networks within a compact geographic footprint. This density creates an ideal environment for genomic medicine delivery at scale.
Yale New Haven Health
A top-ranked academic health system with deep genomics expertise. Yale's clinical genetics program and research infrastructure provide the foundation for advanced molecular diagnostics across the state.
Academic MedicineConnecticut Children's
The state's only freestanding children's hospital, with specialized NICU and pediatric genetics services. A natural anchor for pediatric genomic CarePathways and rapid sequencing programs.
Pediatric SpecialtyUConn Health
Integrating medical education, research, and clinical care under one roof. UConn's academic mission aligns directly with the evidence generation and training needs of a statewide genomics program.
Research & TrainingHartford HealthCare
Connecticut's largest integrated delivery network, extending advanced care into every corner of the state. The community reach needed to ensure equitable access to genomic medicine beyond academic centers.
Community ReachClinical Programs
CarePathways
Structured, evidence-based clinical pathways that bundle genetic testing into value-based care episodes with measurable outcomes. Each pathway defines entry criteria, service bundles, and diagnostic endpoints.
Pediatric & NICU Genomics
Rapid genomic sequencing for critically ill neonates and children with suspected genetic conditions. Diagnosis within the admission prevents the diagnostic odyssey before it begins.
Rare Disease Resolution
Systematic molecular diagnosis for patients on multi-year diagnostic odysseys. Exome and genome sequencing across 20 organ systems with coordinated genetic counseling and follow-up.
Cardiovascular Genetics
Targeted genetic evaluation for cardiomyopathies, arrhythmias, aortopathies, and familial hypercholesterolemia. Cascade testing extends diagnostic value across family units.
Neurogenomics
Genetic testing pathways for epilepsy, neuropathy, ataxia, leukodystrophy, and movement disorders. Molecular diagnosis informs targeted therapy selection and eliminates empiric treatment cycling.
Evidence Base
The Diagnostic Impact
Genetic testing is not an added expense. It is a utilization management tool that eliminates years of downstream waste across the care continuum.
Regional Strategy
New England Network
Connecticut sits at the center of the New England healthcare corridor, connecting academic powerhouses, community health systems, and payer markets across the region.
The New England states share regulatory frameworks, payer populations, and referral networks that make regional CarePathway implementation both efficient and scalable. Connecticut's position between Boston and New York gives it unique access to two of the nation's most advanced medical ecosystems.
By establishing Connecticut as a genomic medicine anchor, the SequenceMedicine network creates a model that extends naturally across New England and into the broader Northeast corridor. Shared infrastructure, coordinated evidence generation, and unified payer engagement amplify impact across state lines.
Value-based bundled care models piloted in Connecticut can inform multi-state payer agreements, creating a positive-sum dynamic where testing more costs less across the entire region.